|
|
|
|
|
|
|
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
|
|
|
|
|
|
|
|
| Array CGH is an emerging technology to detect the chromosomal abnormality. |
|
comparative genomic hybridization (CGH) protocol
new
protocol
CGH protocol with flowchart illustrations from Institute of Pathology, "Rudolf-Virchow-Haus", University Hospital Charité, Humboldt-University of Berlin.
Steps:
Metaphase chromosome preparation
DNA preparation by cryostom tissue dissection
DNA labelin ...
Comparative Genomic Hybridization (CGH) microarrays
new
review
Gene copy number amplifications and deletions are common characteristics of many cancers and identifying these genetic gains and losses provides useful information about the genesis of specific diseases. It is only in the last decade, however, that high-throug ...
Comparative Genomic Hybridization: A Valuable Tool for Genome-Scale
review
A free open access review article from Current Genomics, 2001, 2, 325-335
Comparative Genomic Hybridization: A Valuable Tool for Genome-Scale
Analysis of Rodent Cancer Models
R. Kappler* and H. Scherthan
Department of Human Biology and Human Genetic ...
comparative genomic hybridization resources
new
review
Comparative Genomic Hybridization (CGH) CGH is a molecular cytogenetic method of screening a tumor for genetic changes. The alterations are classified as DNA gains and losses and reveal a characteristic pattern that includes mutations at chromosomal and subchr ...
comparative genomic hybridization CGH images
media
Collection of comparative genomic hybridization (CGH) images from Institute of Pathology, Charité, Berlin.
Metaphase fluorescence images
Metaphase monochrome camera images
Karyogram fluorescence images
Karyogram monochrome images
CGH Sum Karyogram (FITC ...
|
|
Last update: 16-May-2008 01:31 pm
Related new papers and reviews
Integration of conventional cytogenetics (G-banding), comparative genomic hybridization (CGH) and interphase fluorescence in situ hybridization (i-FISH) for the detection of genomic rearrangements in acute leukemia. J Clin Pathol. 2008 May 12; Authors: McGrattan P, Campbell SL, Cuthbert R, Jones FG, McMullin MF, Humphreys M
AIMS: To screen for genomic imbalances in patients with acute leukemia using conventional (G-banding) and molecular (CGH and FISH) methods to see if an integrative screening approach increases abnormality detection rate. METHODS: G-banded analysis was performed on unstimulated BM or PB cells after short-term (24-hour) culture. CGH was performed on reference (control) and neoplastic (test patient) genomic DNA extracted from BM or PB samples. i-FISH was selectively carried out at disease diagnosis on AML and ALL patients using conventional methods. RESULTS: Genomic rearrangements were detected in 4, 7 and 6 patients using G-banding, CGH and i-FISH respectively. Discordance in results between G-banding, CGH and/or i-FISH was found in 7 of the 12 patients screened. G-banding and CGH, when used individually, detected a genomic imbalance/rearrangement in 33.3% and 58.3% of the patients screened respectively. However, when both screening methods were integrated, the abnormality detection rate increased to 66.7%. This detection rate increased further to 75.0% with the use of i-FISH screening. CONCLUSIONS: The advantages and disadvantages of using G-banding, CGH and i-FISH as either stand alone or integrated screening methods for the detection and characterization of genomic imbalances in acute leukemia are clearly demonstrated. Abnormality detection rate significantly increased when an integrated screening approach was employed which could potentially provide valuable information for risk stratification in patients with acute leukemia.
|
|
|
|
|
Copyright 2000-2008 Biowww.net, All rights reserved
|
|
|
|
|
|